165 related articles for article (PubMed ID: 10915075)
1. Changes in the composition of circulating CD8+ T cell subsets during acute epstein-barr and human immunodeficiency virus infections in humans.
Roos MT; van Lier RA; Hamann D; Knol GJ; Verhoofstad I; van Baarle D; Miedema F; Schellekens PT
J Infect Dis; 2000 Aug; 182(2):451-8. PubMed ID: 10915075
[TBL] [Abstract][Full Text] [Related]
2. CD8+CD45RA+CD27-CD28-T-cell subset in PBL of cervical cancer patients representing CD8+T-cells being able to recognize cervical cancer associated antigens provided by HPV 16 E7.
Pilch H; Hoehn H; Schmidt M; Steiner E; Tanner B; Seufert R; Maeurer M
Zentralbl Gynakol; 2002; 124(8-9):406-12. PubMed ID: 12655469
[TBL] [Abstract][Full Text] [Related]
3. Expansion of peripheral CD8+ CD28- T cells in response to Epstein-Barr virus in patients with rheumatoid arthritis.
Klatt T; Ouyang Q; Flad T; Koetter I; Bühring HJ; Kalbacher H; Pawelec G; Müller CA
J Rheumatol; 2005 Feb; 32(2):239-51. PubMed ID: 15693083
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic classification of human CD8+ T cells reflecting their function: inverse correlation between quantitative expression of CD27 and cytotoxic effector function.
Tomiyama H; Takata H; Matsuda T; Takiguchi M
Eur J Immunol; 2004 Apr; 34(4):999-1010. PubMed ID: 15048710
[TBL] [Abstract][Full Text] [Related]
5. Increased activated human T cell lymphotropic virus type I (HTLV-I) Tax11-19-specific memory and effector CD8+ cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with HTLV-I provirus load.
Nagai M; Kubota R; Greten TF; Schneck JP; Leist TP; Jacobson S
J Infect Dis; 2001 Jan; 183(2):197-205. PubMed ID: 11120926
[TBL] [Abstract][Full Text] [Related]
6. Characterization of virus-specific CD8(+) effector T cells in the course of HIV-1 infection: longitudinal analyses in slow and rapid progressors.
Jansen CA; Piriou E; Bronke C; Vingerhoed J; Kostense S; van Baarle D; Miedema F
Clin Immunol; 2004 Dec; 113(3):299-309. PubMed ID: 15507395
[TBL] [Abstract][Full Text] [Related]
7. Properties of murine (CD8+)CD27- T cells.
Baars PA; Sierro S; Arens R; Tesselaar K; Hooibrink B; Klenerman P; van Lier RA
Eur J Immunol; 2005 Nov; 35(11):3131-41. PubMed ID: 16220536
[TBL] [Abstract][Full Text] [Related]
8. High responsiveness of HLA-B57-restricted Gag-specific CD8+ T cells in vitro may contribute to the protective effect of HLA-B57 in HIV-infection.
Jansen CA; Kostense S; Vandenberghe K; Nanlohy NM; De Cuyper IM; Piriou E; Manting EH; Miedema F; van Baarle D
Eur J Immunol; 2005 Jan; 35(1):150-8. PubMed ID: 15593302
[TBL] [Abstract][Full Text] [Related]
9. CD8+ T cell responses to human immunodeficiency viruses type 2 (HIV-2) and type 1 (HIV-1) gag proteins are distinguishable by magnitude and breadth but not cellular phenotype.
Gillespie GM; Pinheiro S; Sayeid-Al-Jamee M; Alabi A; Kaye S; Sabally S; Sarge-Njie R; Njai H; Joof K; Jaye A; Whittle H; Rowland-Jones S; Dorrell L
Eur J Immunol; 2005 May; 35(5):1445-53. PubMed ID: 15832290
[TBL] [Abstract][Full Text] [Related]
10. CD8 T cell effector maturation in HIV-1-infected children.
Jordan KA; Furlan SN; Gonzalez VD; Karlsson AC; Quigley MF; Deeks SG; Rosenberg MG; Nixon DF; Sandberg JK
Virology; 2006 Mar; 347(1):117-26. PubMed ID: 16406047
[TBL] [Abstract][Full Text] [Related]
11. Different contribution of EBV and CMV infections in very long-term carriers to age-related alterations of CD8+ T cells.
Vescovini R; Telera A; Fagnoni FF; Biasini C; Medici MC; Valcavi P; di Pede P; Lucchini G; Zanlari L; Passeri G; Zanni F; Chezzi C; Franceschi C; Sansoni P
Exp Gerontol; 2004 Aug; 39(8):1233-43. PubMed ID: 15288697
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of CXCR4 expression on human CD8+ T cells during peripheral differentiation.
Kobayashi N; Takata H; Yokota S; Takiguchi M
Eur J Immunol; 2004 Dec; 34(12):3370-8. PubMed ID: 15549771
[TBL] [Abstract][Full Text] [Related]
13. A11 Tetramer-assisted characterization of Rta-specific CD8+ T-cell responses in healthy virus carriers.
Yu HX; Srinivasan N; Ren EE; Chan SH
Tissue Antigens; 2005 Jun; 65(6):539-43. PubMed ID: 15896201
[TBL] [Abstract][Full Text] [Related]
14. Skewed maturation of memory HIV-specific CD8 T lymphocytes.
Champagne P; Ogg GS; King AS; Knabenhans C; Ellefsen K; Nobile M; Appay V; Rizzardi GP; Fleury S; Lipp M; Förster R; Rowland-Jones S; Sékaly RP; McMichael AJ; Pantaleo G
Nature; 2001 Mar; 410(6824):106-11. PubMed ID: 11242051
[TBL] [Abstract][Full Text] [Related]
15. Frequency and phenotyping of human immunodeficiency virus (HIV)-specific CD8+ T cells in HIV-infected children, using major histocompatibility complex class I peptide tetramers.
Scott-Algara D; Buseyne F; Blanche S; Rouzioux C; Jouanne C; Romagné F; Rivière Y
J Infect Dis; 2001 Jun; 183(11):1565-73. PubMed ID: 11343205
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory process of CD8+ CD28- T cells in induced sputum from asthmatic patients.
Hamzaoui A; Chaouch N; Graïri H; Ammar J; Hamzaoui K
Mediators Inflamm; 2005 Aug; 2005(3):160-6. PubMed ID: 16106102
[TBL] [Abstract][Full Text] [Related]
17. Functional and phenotypic analysis of human memory CD8+ T cells expressing CXCR3.
Kobayashi N; Kondo T; Takata H; Yokota S; Takiguchi M
J Leukoc Biol; 2006 Aug; 80(2):320-9. PubMed ID: 16861617
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of human granzymes A, B, and K in natural killer cells and during CD8+ T cell differentiation in peripheral blood.
Bratke K; Kuepper M; Bade B; Virchow JC; Luttmann W
Eur J Immunol; 2005 Sep; 35(9):2608-16. PubMed ID: 16106370
[TBL] [Abstract][Full Text] [Related]
19. BY55/CD160 cannot be considered a cytotoxic marker in cytomegalovirus-specific human CD8(+) T cells.
Merino J; Ramírez N; Moreno C; Toledo E; Fernández M; Sánchez-Ibarrola A
Clin Exp Immunol; 2007 Jul; 149(1):87-96. PubMed ID: 17425655
[TBL] [Abstract][Full Text] [Related]
20. CD8+ T cells from most HIV-1-infected patients, even when challenged with mature dendritic cells, lack functional recall memory to HIV gag but not other viruses.
Arrode G; Finke JS; Zebroski H; Siegal FP; Steinman RM
Eur J Immunol; 2005 Jan; 35(1):159-70. PubMed ID: 15580653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
